131 results
Page 2 of 7
8-K
EX-10.1
zo1kgs9
2 Aug 22
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-10.1
5wq2iq8b0ps0zhx7 229
27 Jul 22
Entry into a Material Definitive Agreement
7:08am
8-K
ud35q 24v9s3
2 Jun 22
Submission of Matters to a Vote of Security Holders
4:30pm
DEFA14A
47qyk86f6v0t 2d
20 Apr 22
Additional proxy soliciting materials
4:09pm
8-K
EX-1.1
0siwcynp jrff0x
24 Mar 22
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
8:18pm
424B5
o04epvsdh0lschfad
24 Mar 22
Prospectus supplement for primary offering
8:02pm
424B5
6r76 19cyk
23 Mar 22
Prospectus supplement for primary offering
5:14pm
S-8
chr 3e71ixpd
28 Feb 22
Registration of securities for employees
5:06pm
S-8
EX-23.2
4uczowr
28 Feb 22
Registration of securities for employees
5:06pm
8-K
EX-1.1
u940l 2gv
20 Jan 22
Entry into a Material Definitive Agreement
4:55pm
424B5
v8n71cpwbn
20 Jan 22
Prospectus supplement for primary offering
4:45pm
8-K
dq6x l8ucr9
10 Jan 22
Results of Operations and Financial Condition
8:00am
8-K
EX-1.1
g53teg46gwj7a0mv9gc5
17 Nov 21
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
9:04am
424B5
sibcvbsmemn19vzfu00r
17 Nov 21
Prospectus supplement for primary offering
9:02am
424B5
aevs1osl
15 Nov 21
Prospectus supplement for primary offering
5:24pm